RNF19A and breast cancer: RNF19A protein level was overexpressed in more than half (79/140, 56.4%) of the BC tissues and this group of patients exhibited improved overall survival (OS) (Supplementary Fig. 6e), while only 23.9% (11/46) of the non-BC tissues were stained positively for RNF19A.